Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

Astrazeneca (AZN) concluded the recent trading session at $94.01, signifying a -1.21% move from its prior days close.…

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmakers…

J&Js diversified pharma and MedTech strength stacks up against AstraZenecas oncology-led growth as investors weigh stability versus faster expansion.…

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is set to deliver a solid finish to 2025 when it reports fourth-quarter results next month,…

2 January 2026Transparency DirectiveVoting rights and capitalThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Berkshire Hathaway headlines new Zacks research reports, with strong insurance performance, cash strength and diversified growth drivers.…

The festive period is, for some, a time for taking stock of whats happened in the past year - for…

AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply…

AstraZenecas Enhertu wins FDA Breakthrough tag for expanded use in breast cancer, while a late-stage study on ceralasertib + Imfinzi…

Hong Kong-listed Chinese biotech firm Jacobio Pharma says it hopes to commercialize a new drug that its developing with AstraZeneca.…

AstraZenecas Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.…

IRW-PRESS: ACCESS Newswire: Eastman, AstraZeneca, Kraft Heinz und P&G mit OMP Supply Chain Awards ausgezeichnetMIAMI, FLORIDA / ACCESS Newswire /…

AstraZeneca’s Saphnelo approved in EU for self-administration in lupus…

Astrazeneca (AZN) closed the most recent trading day at $91.56, moving +1.93% from the previous trading session.…

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for…

JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…

JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für Novartis von 95 auf 125 Franken angehoben…

AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.…

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations…